In short
How the body keeps blood sugar in a narrow safe range (~4 grams of glucose in the bloodstream at any moment) using insulin and glucagon, and how GLP-1-based drugs (e.g., semaglutide/Wegovy/Ozempic) exploit gut-brain signaling to reduce hunger and improve glucose control.
Key claims
Insulin opens “glucose doors” on muscle/fat cells; without it (type 1 diabetes), cells starve despite high blood sugar. Glucagon tells the liver to release/make glucose during fasting. Gut signals explain why oral glucose triggers more insulin than injected glucose. GLP-1 rises after eating, increases insulin only when glucose is high, reduces glucagon, slows stomach emptying, and acts on brain receptors to reduce hunger (“food noise”).
Notable examples
stomach-ulcer surgery causing hypoglycemia via rapid meal dumping; discovery of GLP-1-like peptides from the anglerfish gene; GLP-1 degradation by DPP-4; Gila monster venom peptide (exendin-4) inspiring longer-lasting drugs; semaglutide lasting about a week.
Guests
No external guests—episode is hosted by Michael Stevens and Hannah Fry.
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Chapters
Tap a time to open that second in VOThe Sweetness in Our Blood
0:45 to 2:30
Discussion on blood sugar levels and how the body regulates them.
“But I don't remember at all what I calculated.”
Sponsor: Cancer Research UK
2:30 to 3:54
Promotional segment about Cancer Research UK and their contributions.
“Our bodies are incredible machines, whirring away, making more and more DNA to build the proteins that keep us alive.”
The Balance of Hormones
3:54 to 4:37
Explaining the role of insulin and glucagon in blood sugar regulation.
“Ready to make anything online make sense?”
The Insulin Response Mystery
4:37 to 8:08
Exploration of how the body reacts differently to glucose intake methods.
“Okay, there's two main hormones that are in charge of keeping this incredibly fine balance.”
The Science of Digestion and Insulin
8:08 to 14:02
Discussion on how food digestion affects insulin release and blood sugar levels.
“Yeah, obviously insulin would be their sibling.”
Unpacking GLP-1 and Diabetes Treatments
14:02 to 29:02
Explore the discovery and function of GLP-1 in managing diabetes.
“Anyway, they were like, right, we want to know what gene is creating this.”
Understanding GLP-1 Hormones
29:17 to 33:00
Discover how GLP-1 affects hunger and insulin regulation.
“And the answer is there's four things with varying degrees of us understanding them.”
The Business of Food Consumption
33:00 to 35:25
Explore how food companies influence consumption and health.
“Except that there's the other capitalism of it on the other side.”
Impact of GLP-1 on Behavior
35:25 to 38:54
Learn how GLP-1 modulates desire and consumption behaviors.
“You're hungry because you have overridden the systems that your body has in place to tell you when to stop eating.”
Future of GLP-1 and Alzheimer's Research
38:54 to 41:41
Discuss the potential of GLP-1 in cognitive decline therapies.
“you exist without the desire and the need and the drive to consume, whether it be food or or even experiences like gambling.”
Show all 14 chapters
Advancements in Protein Research
41:41 to 42:09
Discover how AI aids in understanding protein folding.
AI in Protein Folding Breakthroughs
42:09 to 44:32
Learn about how AI is revolutionizing our understanding of protein folding and potential Alzheimer's treatments.
“There's one in particular, which is called alpha fold.”
The Duality of AI in Medicine
44:32 to 45:38
Discover the potential and risks associated with AI in drug development and biological warfare.
“You can also use it to find their antidotes, right?”
Listener Engagement and Show Wrap-Up
45:38 to 47:58
Find out how to engage with the show and stay connected for future episodes.
“Yeah, that's my little tour, the history and wonder of GLP-1s and the little family.”
Transcript
Automatic transcript. May contain errors.0:00Hannah Fry:Hello and welcome to The Rest is Science. I am Michael Stevens. And I'm Hannah Fry. Michael, you know, if you ask somebody if they want sugar in their tea and they respond, no, thank you. I'm sweet enough. Here's my question for you. How sweet are you? I want to know how much sugar do you think there is in your bloodstream right now? Did you know that I've actually calculated this before? Have you? Yes, I did this entire series of videos for a diabetes medication company. for giving to doctors. They were never public. And the scripts they wrote were so boring. I did a bunch of like V-saucing them up.
0:37And I calculated like if a diabetic person with really high blood sugar got bit by a vampire, would they be a dessert? Turns out no. But I don't remember at all what I calculated. But yeah, I did calculate like how sweet is my blood? Is someone with low blood sugar, high blood sugar? I think that like diffused into my whole body, I'm not that sweet.
0:59Hannah Fry:Vampires have not got sweet tooths, you know, because even a diabetic person with like all this sugar running around in their blood, it's not going to taste that sweet. But you, on the other hand, Michael, I mean, I haven't done the exact calculations. I didn't, I didn't want to sort of email through in advance for your height and weight, but it's about four grams in your blood. That's it. That's it. Like a teaspoon, basically. Wow. A little teaspoon. A little teaspoon in your blood at any moment in time. You can eat a massive dessert and your body will be like, nope, too much. Thank you. You need to lock some of that away.
1:30Hannah Fry:Or you can do a starvation diet and have none there and your body will be like, what? Not okay. Thank you. You need to put more in. This is like an incredibly narrow window that your body is continually fighting. High blood sugar doesn't mean 400 grams. It means a little bit more than four. And low blood sugar is a little bit below that narrow path, that narrow band where we are fine. Exactly. So what I want to talk about today is how your body manages this incredible dance of keeping your blood fine, whatever you throw at it. And then in turn, how people are now hacking our own biology via fat traps in order to disrupt this system to our advantage.
2:29This episode is brought to you by Cancer Research UK. Our bodies are incredible machines, whirring away, making more and more DNA to build the proteins that keep us alive.
2:40Hannah Fry:In fact, in the last minute, your body has made over 200 million new cells and enough DNA to stretch to the moon and back. To the moon and back. That's so much DNA that if you compared it to the size of the cell it fits into, That would be like squeezing the London Underground into a suitcase. By the age of 50, you have copied almost 6 trillion miles of DNA. But every time that your body copies DNA, it risks making mistakes. And over time, those mistakes can accumulate and that collection of errors can lead to cancer. But incredibly, Cancer Research UK scientists can spot these errors. And by finding them, they've helped double UK cancer survival over the last 50 years.
3:24and are driving even more discoveries that could tackle over 200 types of cancer.
3:28Hannah Fry:For more information about Cancer Research UK, their research and breakthroughs, and how you can support them, visit cancerresearchuk.org slash rest is science.
3:54weeks. Gemini and Chrome is here for it. Ready to make anything online make sense? There's no place like Chrome. Check responses set up required, compatibility and availability varies 18 plus. Late night bites with friends? Already hard to beat. That first too hot bite of fries you couldn't wait for, followed by ice cold Pepsi. Now that hits different. Suddenly, the energy kicks back in, the night goes longer, and the laughs don't stop. Because Pepsi brings out more flavor, more fun, and more of the moment. Food deserves Pepsi. Grab a Pepsi Zero Sugar today.
4:37Hannah Fry:Okay, there's two main hormones that are in charge of keeping this incredibly fine balance. One of them is insulin, which of course is the one that's the problem when people have diabetes. Do you know how insulin actually works, though? It's kind of clever. Okay, I thought you said, do you know how internet works? And I was like, whoa, it's a bunch of tubes is all I know. Insulin, I don't remember. At top level, insulin is produced by your pancreas. When you have too much blood sugar, if you're all fine and good, it will take away excess sugar from your blood and put it into storage. That's sort of like the top line level.
5:11When it stores it, it doesn't store it as sugar.
5:14Hannah Fry:Correct. the way that it works is all of your muscle and fat cells, they have, I mean, simplifying slightly here, but they essentially have like little doors in their walls that glucose can pass through. These are like very specific little protein gates. But normally those doors are locked close, right? The glucose can't get in. So that any glucose that's within the cell stays within the cell. It's not sort of floating in and out. And then what happens is that insulin is essentially like the lock for this door. So as insulin comes past, it opens up the door, the glucose can one So if you do not have insulin in your body, if you have like a deprivation of insulin in your body, then you can have glucose literally standing right outside of a cell being like, hello, please let me in.
5:55Hannah Fry:And it just can't get in, right? If the insulin doesn't dock into its receptor to open the door, there's like sort of nothing going on. So this is what's happening when people, especially with type 1 diabetes, this is exactly what happens. your blood can be completely full of sugar, way, way, way above the four grams that's sort of normal. But because the doors are not unlocking, your cells can't get any. So your body is like starving to death despite there being this insane abundance of fuel right next door. Wow, wow. And by the way, glucose is the type of sugar that our body uses. If I eat a bunch of fructose or lactose or some other kind of sugar, the body goes, okay, cool.
6:39But we need to have glucose for the cells to have the energy they need.
6:43Hannah Fry:Exactly. I mean, that's the whole thing about energy is it's glucose plus oxygen equals water plus carbon dioxide plus energy. That's literally the thing that your cells are running on. So I use the energy to move. I breathe out the carbon dioxide. Thank you, glucose. Thank you very much, glucose. Appreciate it. But without insulin, you're in trouble, right? You're really in trouble. Anyway, at the other end of the spectrum, so that's what happens if you have too much sugar in your blood. That's what's supposed to happen is that all these doors open and then it goes in and it gets stored. At the other end of the spectrum, you have something called glucagon, which is actually also, I think, created very close by in the pancreas.
7:24Hannah Fry:And this gets released when the blood sugar is low instead. So like if you're fasting or overnight or whatever it is, and that goes to the liver. And then the liver is sort of like the body's pantry. It can break through stored glucose, stored as glycogen, can break it back down into glucose. It can pour it into the blood and it can even manufacture sort of brand new glucose from scratch out of amino acids and other spare parts, right? If you really need to. By the way, glucagon would be a great name for a child. Glucagon, put down your sister's toys. Wait, are we saying glucagon is male or female?
8:01It could be either. It's just a great name for a child that makes everything sweeter.
8:06Hannah Fry:Well, that's true. Adds in sugar. Adds in sugar when required. What about insulin as a child's name? Yeah, obviously insulin would be their sibling. Yeah, necessary, but robs the sweetness. That's right. Okay, so here's this puzzle, right? So obviously people with type 1 diabetes have existed for probably as long as people. but here is a real puzzle that bothered doctors and scientists for a really long time. If you take some glucose and you drink it, right, let's just say you take some leucosate or something, right, something really, really sugary and you drink it, your blood sugar rises as expected and your pancreas will dump out loads of insulin to sort of deal with it, to kind of clean it up and make sure it doesn't get too much.
8:47Hannah Fry:Fine, expect it. Now, if you take exactly the same amount of glucose, not as Lucas said this time, but as the same amount of glucose, and instead you just inject it directly into a vein, you're bypassing the gut, but it's the same sugar, same blood concentration. You would expect that your pancreas should react in the same way. It should be like, okay, loads of sugar here dumps out loads of insulin, but it doesn't. What actually happens is your pancreas does produce insulin, but way, way less, like half as much as it does if you actually ingest it. People notice something like, that is very strange, right?
9:24Hannah Fry:That like the only difference that's going on here is the root that it gets into your bloodstream, but still it's about being in your bloodstream. So this was, I think, one of the first clues that people were like, okay, it looks like something is happening in your gut or in your mouth as you're literally ingesting something that is telling your pancreas to produce more insulin. You can't bypass the gut or the pancreas acts differently. Right. There's something going on here. And so in the 1980s, stomach ulcers used to be a really, really big thing. Do you remember like when I was a kid, you would hear about, oh, it's got a stomach ulcer, like a stress, stomach ulcer.
10:04Hannah Fry:It's really awful. Yeah. And you heard about this in movies and the media all the time. Like every dad had an ulcer that was getting worse because the kids were loud. I thought that would be a much bigger part of my life today. Yeah, but you don't see them anymore at all. It's like the Bermuda Triangle, like the 90s were full of all these things that I learned to be very, very aware of and fear. And then now I'm just like, hey, what happened to the Bermuda Triangle? What happened to ulcers? Not that they've gone away, but yeah, yeah, you're right. Not completely, but they sort of have because it turns out that they were caused by bacteria.
10:36Hannah Fry:There's a great story about how they proved that it was a bacteria because the person who came up with the discovery decided to swallow, to drink the bacteria, deliberately give himself a stomach ulcer. in order to then demonstrate that that was the thing that caused it. Anyway, that's by the by. Right. So drinking someone's ulcer, bad idea. It's contagious. Don't lick the inside of someone's stomach if they're infected with ulcers. Let me just write this down because actually, no, I need to cross it off. It's on my list of to-dos today. But yeah, ulcers weren't caused by a stressful job. I mean, I think it probably exacerbated it.
11:13Hannah Fry:your immune system would be more liable to be unable to fight something and so on. Okay, here's the thing. What they used to do, which actually seems brutal now, I think when you think about it, is if people had stomach ulcers, they would be like, well, I don't know, should we just cut out that bit of the stomach? Like, should we just go in there and like lop it out maybe? I think they would only do it if someone had a particularly nasty ulcer. They'd go in, they would like cut out the bottom of your stomach. Okay, and the way your stomach is sort of like this, it's kind of almost like a u-bend shape right sort of like dips below and then comes back up what then happened was some of these patients started having these really bad low blood sugar attacks they'd be like really shaky they'd be really sweaty they'd be like faint and hypoglycemic they were like what on earth is going on with these people like why why is this happening and they worked out that it was because their bodies were pumping out more insulin than it should have been.
12:12Hannah Fry:So it was like depleting all of the sugar that was in their blood really quickly. The balance was off, essentially. Let me get this straight. So if you eat the glucose, then normally everything's fine. If you inject it and bypass the gut, not enough insulin is made. Correct. If you cut part of the stomach away and you eat the sugar, then too much insulin is made. Exactly. So there's some sort of messaging signal that's going on. When you ingest food all the way through, some messaging system is going on that is telling the pancreas to release the correct amount of insulin. And they worked out essentially that what was happening, that down there in the bottom of the stomach is this little muscular valve.
13:01Hannah Fry:And what it's doing is it is, its whole job is to be really stingy, right? Is to like hold back everything in the stomach and then squirt it through really carefully, like drip, drip, drip, drip, drip. Now, if you take that valve out, the food doesn't drip, it like dumps, the whole meal kind of comes crashing through into the lower gut all at once, right? And so they were like, okay, well, this signal, maybe the signal is around about there somewhere because as all this food is like getting dumped in the signal is going like what like crazy we need insulin now we need loads of insulin way way way faster than the body needs it or can handle it and that's what's making people be high glycemic all of this is going on these couple of scientists in boston and harvard they were like okay this whole thing about glucagon which isn't their son unfortunately Or daughter.
13:56Hannah Fry:Or daughter. Any kind of child should be called glucagon. That's the official policy of me. Okay. Anyway, they were like, right, we want to know what gene is creating this. And they were particularly interested in the anglerfish because the anglerfish has this entire organ, which is called the Brockman body, for making glucagon. Okay. So normally you've got a pancreas in a human or in other animals. And if you want to go in and you want to work out where the glucagon is being made, you've got like kind of pick out tiny little bits of glucagon and it's all mixed in with other bits really difficult but in the angler fish it's really simple so what they did is they managed to find the gene for glucagon via this fish and then they were really surprised to discover that this this gene also makes two other little peptides peptide by the way anyone who has like ever experienced a skincare advert will think that it's something that you put on your face peptide is It's just a cute little chain of amino acids.
14:54Hannah Fry:Okay, that's all it is. It's like a little cute, cute little, cute little peptide. A cute word for a cute thing. Peptide is another great child's name. Hey, peptide. We've got triplets now. I think peptide should be the pet. Should be like a little mini chihuahua, you know? It's the little dog. It's the little dog. I love this little family that we're creating, Hannah. We've got to decide what the mum and dad are called at some point. Yeah, we will. but one of them surely is called ulcer. Ulcer, that's the dad. And the mom, TBH, TBD. TBH, what is TBH to be honest? Oh gosh, the kids are gonna blast me for misusing an acronym.
15:36Hannah Fry:I think you'll feel right. Okay, so this gene that makes glucagon turns out also makes these two little peptides and they're looking at them and they're like, well, I don't know what this is. Oh, it's sort of a bit like a glucagon. It's glucagon-like. A glucagon-like peptide? Let's call them glucagon-like peptide 1 and glucagon-like peptide 2. GLP-1 and GLP-2. There they are. You may have heard of GLP-1. Yeah. Because this is the hormone that fat jabs aim to mimic. Things like azempic, wagovi, manjaro, all of those. It turns out that you have these little factories. They are essentially this messenger system directly to your pancreas to say, hello, we're going to get some insulin out there because otherwise our blood sugar is going to end up being a bit too high.
16:29Okay, so that's what GLP-1 does. It's a messenger to the pancreas to make insulin?
16:37Hannah Fry:Well, yes, but only if the blood sugar is high. The reason why people were so excited about this is because if you have somebody with diabetes, right, and you just whack a load of insulin into their bodies, well then great, you know, you've dealt with that particular sugar high, but you need to assess it really carefully because you could accidentally put too much in and then have their sugar levels dropping off the charts instead. Yeah. It's unbelievably difficult to get that balance, that incredibly fine balance, right at all times. Because also if you have blood sugar that's too low, I mean, your brain literally starves.
17:17Hannah Fry:Yeah. It cannot function. I mean, it's really, really dangerous. But if you have too high a sugar in your blood, then you sort of candy all of your, all of your internal organs, you know, your eyes in particular are really, really susceptible to going blind if there's too much sugar in your blood for a long period of time. The thing about this GLP-1 that everyone was excited about was like, okay, so insulin is like, it's kind of, it's kind of fixing the problem with a sledgehammer, you know, which is like, better than nothing, but still not great. But GLP-1 will only signal the pancreas to produce more insulin if you have high blood sugar.
17:59Hannah Fry:So if you've got GLP-1 floating around and your blood sugar is low, your pancreas will not go crazy. It's only because the reason why you've got such big spikes in the people who'd had those stomach ulcers removed was because this great big dump of food coming through the stomach coincided with there being a lot of sugar in the blood and therefore the pancreas overreacted. So in 1993, this Danish scientist, he's called Jens Juhlholst, he was like, okay, well, let's try this, shall we? Should we just whack a load of this peptide, this cute little peptide, GLP-1, into people's bodies, see what happens?
18:37Hannah Fry:And he did it with people who had diabetes in particular, right? So this is all about a diabetes medication. So for starters, having GLP in the body did normalize people's blood glucose levels, right? So it worked. But he says, the first problem was that we realized that injecting people with simple subcutaneous injections of this peptide ultimately didn't really work. The reason was that the peptide was destroyed in the body within minutes, so it couldn't be done that way. And you couldn't give them a higher dose because they just start to puke all over the place. So that didn't work either. That's the scientific term, puke all over the place.
19:12Hannah Fry:This is essentially where this is going. Did this scientific study, injected people, they just all started puking all over the place, which is, I mean, tells you that like flooding your body with this stuff is not good. But the other point about how it gets broken down by the body really quickly, like this made it sort of, okay, maybe there's this miracle drug somewhere, but it's not going to work because essentially your body, in order to keep that incredibly fine balance, that four grams of sugar, You can't let the GLP-1 like float around for too long, you know, because then you'd be like carrying on putting out insulin long after the blood sugar had been dealt with.
19:51Hannah Fry:So you also have this little enzyme in your blood, which is called DPP-4. I don't know if that's going to be the mother's name. That's the mom. That's the mom. We met her. She's here. Yeah, maybe we shouldn't call the mom that because it sounds like a very awkward question. What's DPP-4?
20:13Hannah Fry:She's here. She's snippy though, the mum. I mean, that's essentially her job is to go along and cut GLP-1 in half. And destroy it. I don't think she's, I mean, she's good. She's keeping everything balancing, but she's sort of, she's doing it by cutting the play in half, you know? Yeah. Yeah, everyone was like, you know, it feels like we're onto something, but everyone's puking and it doesn't work. So it's not looking so good. And then enter into the frame the unusual family pet, the Gila monster. So this is a lizard, right? Because the Gila monster solves everything, my friend. The Gila monster is the root source of this miracle that happened with diabetes.
20:58Hannah Fry:Tell us about the animal. It's a venomous lizard, lives in America. It's quite fat. It's quite chunky. It's got like this orange black skin kind of mottled. They live in the desert. They're like, they're quite lazy. They don't move very fast. So they only actually managed to catch and eat a meal about five times a year. No kidding. Yeah. Have you eaten this quarter? Okay. I can see how this is related. But when they do, when they do, they eat like half their body weight all at once. Right. Okay. But scientists were like, right, well, this guy over here, this Gila monster is like, He's going very long periods without eating.
21:36Hannah Fry:They've got to have some way to keep this balanced, you know, their metabolism running really smoothly throughout that time. The thing is, one of the reasons why you might know the Guillain-Monts-Date is that they bite humans. Oh, they can bite humans. The bite is venomous. It causes this incredible pain. Something else kind of separately that scientists had noticed in the 1970s and 80s when people had been bitten was that the victim's pancreas would start secreting all kinds of hormones. Really? I mean, you're absolutely seeing where this is going, right? Yeah. A team of scientists, they decided they would get the venom of this Gila monster and they would test it on pancreas cells to see if any of them did anything, which is really difficult because it's like this kind of tangled web of molecules, right?
22:20Hannah Fry:But there's one venom in particular that makes a pancreas start secreting and they wrote this paper about it. They just left it. It was untouched for like 10 years. No one touched it. No one went anywhere near it. And then in the early 1990s, this different doctor, Dr. John Eng, read this paper and was like, oh, I wonder what, I wonder what venom spit from the Gila monster is doing to the pancreas. That's like so weird. He found in this venom, this chain of 39 amino acids, acutelylt peptide, and he called it Xendin4. You really need to get better names for these things. Xendin4. Is that the mum?
23:03Hannah Fry:Xendin4. That's the second wife, maybe. I think that might be the car number plate. Okay, fair enough. Yeah, I like that. Anyway, the thing is, it turns out that this little peptide is almost the same as GLP-1. like they're really, really similar, but it is different in one important way, which is that venom has to be stable, right? Like the animal makes the chemicals and the venom and it sort of sits inside the animal's body. So it has to last way longer without breaking down. And the crucial thing is that the peptide in this gila monster's spit, instead of like disappearing in a few minutes like GLP-1 does, can last for ages and ages and ages.
Read the full transcript
23:50Hannah Fry:And the reason why is that the enzyme can't cut it. DPP-4 can't cut it up. It's blocked. It's blocked. I mean, this is like an unbelievable revelation. I think just really demonstrates the way that science sort of inches forwards towards progress. Because over here, someone's looking at venom bites in lizards. Over here, somebody's looking at patients with diabetes. Over here, somebody's looking at stomach ulcers. And then it ends up all coming together. And this lizard that eats four times a year turns out is carrying in its spit as an almost perfect human version of the satiety hormone that sort of makes you feel full.
24:36Hannah Fry:It's absolutely crazy that this is the case. Is that what GLP-1 does? It makes you feel full? Yes, well, I'll get to that in a second because we don't know totally how it completely works. We know a bit about how it works, but one of the things is it makes you feel full. So Xenidin 4 lasts longer than GLP-1. Because it can't be cut. If you inject someone with a bunch of it, does it make them puke all over the place? Well, you still have to be quite careful about that. But okay, for starters, they didn't harvest the venom of a monster, the spit of a monster to do it. They like manufactured synthetic versions of the same thing.
25:14Hannah Fry:The very first class of these drugs were just copying the lizard's protein. But the modern ones, what they've done is they've like tweaked it a tiny bit. So they've tweaked the spot where the enzyme, where DPP4 can latch onto so that it can't really get a grip anymore. So there's no risk of it sort of breaking down. And then they've also added on, I just find this crazy about modern microbiology is absolutely astonishing. they've like added on this little tail this little like fatty tail off it which can hook onto the albumin which is this really big carrier protein that kind of floats around your blood is hitching a ride essentially on like the main train so that it can move around your body and and because it's hitched a ride it can't get filtered out by your kidneys so it's like it stays in your body for longer as well so so you've moved from glp1 which is a molecule that you make yourself that lasts about 90 seconds before it gets cut up by the wife.
26:10Hannah Fry:And now you've got semaglutide, which lasts for a week in your body. That's the whole thing. You haven't invented anything new. You've just taken like a body's own process. And then you've made that process instead of lasting for 90 seconds after you've eaten a biscuit, instead lasts for, you know, a whole seven days. Wow. That really is incredible. Who was the dad again? The dad, dad was ulcer. The dad was ulcer. He's got a bit part in the story, let's be honest. Yeah, this is the dad who like went out for cigarettes and never came back. GLP-1 came around, but it still wasn't quite perfect. But then the dad put in the work and he grew as a person and became this manufactured semiglutide that sticks around, hitches a ride, does the work.
27:01That's just incredible. Isn't it?
27:03Hannah Fry:I tell you what, let's go for a break. And then when we come back, I'll answer your question because you have asked about four times, what is it actually doing? And I have got an answer for you ish.
27:51We'll be right back.
28:03flavor, more fun, and more of the moment. Food deserves Pepsi. Grab a Pepsi Zero Sugar today.
28:12Hannah Fry:Hey, it's Kelly Rowland. You may not know this, but I have eczema. So I get how it can steal your time. But why let eczema take over when you can talk to your doctor about EBCLIS? EBCLIS Lubricizumab LBKZ, a 250 milligram per two milliliter injection, is a prescription medicine used to treat adults and children 12 years of age and older who weigh at least 88 pounds or 40 kilograms with moderate to severe eczema. Also called atopic dermatitis that is not well controlled with prescription therapies used on the skin or topicals or who cannot use topical therapies. EbGliss can be used with or without topical corticosteroids.
28:46Don't use if you are allergic to EbGliss. Allergic reactions can occur that can be severe. Eye problems can occur. Tell your doctor if you have new or worsening eye problems. You should not receive a live vaccine when treated with EbGliss. Before starting EbGliss, tell your doctor if you have a parasitic infection. Paid partnership with Lilly.
29:00Hannah Fry:Respect your time. Ask your doctor about Epclus and visit epclus.com or call 1-800-LILLY-RX or 1-800-545-5979.
29:16Hannah Fry:Okay, we're back. You've asked, what do they actually do? Yeah. And the answer is there's four things with varying degrees of us understanding them. hold on we're talking about glp1 glp1 yeah okay because because semiglutin is doing the same thing it's like it's the same shape as glp1 that's doing the same thing it's just got these additions to stop it being like chopped apart yeah we know glp1 goes to the pancreas tells it to make insulin when the blood sugar is also high right that is what makes it an amazing medication for diabetics. It's also why your, you know, your blood sugar doesn't crash to the floor.
29:59Hannah Fry:It sort of, it keeps you regulated in a really good way. It also, so as well as increasing your insulin, it also calms down your glucagon. Okay. This is the one, of course, that's telling your liver to sort of pour stored sugar into the blood. So it's just on both ends of the, on both ends of that spectrum is just saying, guys, calm down. All right? No big deal. Just like a good dad, you know? Yeah. It kind of keeps the peace, lets everyone talk. I love it. Okay. It also, we know that it slows down how fast your stomach empties into your intestines. That means essentially that food is going to sit in your stomach for longer.
30:41Hannah Fry:It's going to, sugar will trickle in much slower instead of arriving in a flood. Which, I mean, if you, I don't know, like you sort of know to do this anyway. I think people broadly know that having something like porridge for breakfast is better, especially with like rolled oats or whatever is better than having pancakes with maple syrup. And it's because the sugar is being released more slowly. Well, better depends on what your goal is. If your goal is to get really sugared up, then just drink the syrup. But yeah, if you want that long release of energy, you have the porridge. I mean, this is true.
31:18Hannah Fry:But I think the effect of that is that it also just makes you feel physically fuller for a longer time. Ah, and there's the rub. There is the rub. But here is the ultimate, ultimate rub, because GLP-1 manages to talk to your brain. There are receptors for GLP-1 in the hypothalamus. There is a little patch in your brainstem. And when GLP-1 lands there, it basically turns down the volume on hunger. It's not like, oh, I'm being disciplined and I'm not going to eat. I'm going to push myself through. It's like, it just doesn't even occur to you. The desire is not there. The desire is not there. This is the thing that really makes it this amazing, amazing intervention for obesity.
32:05Hannah Fry:Because it's not speeding up your metabolism. It's not blocking fat. It's not a stimulant. It's not like, you know, dissecting sections of your stomach like gastric bands used to. It's just changing the demand. Like that's it. It's just turning down the dial on how you think about it. I'm a little surprised because I thought that the big innovation we would see would be that we would find a way to allow people to continue to desire and consume a lot of food without any problems health-wise because that's what made more sense for companies. Like, they need to sell all this food to us. And the more food we buy, the more their profits go up and the happier their boards are.
32:50But a medication that causes a decrease in demand sounded too anti-capitalism to ever take off. And yet, here we are. Except that there's the other capitalism of it on the other side.
33:03Hannah Fry:That's right. That's right. In the sense of like the capitalism of selling the drug. Right. I think you make a really important point here, which is that when companies have been making foods, whether it's like breakfast cereals or, you know, like crisps that you might snack on, over and over again, especially if that food has existed for a really long time, the thing that the company is trying to optimize for is volume. You know, you go in and you have like a sit down, a consumer panel where they all try the stuff. And of course they're asking them, How delicious is it? Did you enjoy it? Was it really tasty?
33:35Hannah Fry:But the thing they care about most was how much did you eat? What volume did you consume? And I mean, I'm not just saying this is like a hunch, right? Like there is so much evidence that this has been the metric that these companies have optimized for over and over again. And it should have been because if I'm investing in these companies, I need them to have customers that want to consume, consume, consume. otherwise they don't grow. Right except that the way to get people to consume more and more food isn't to make it more and more delicious it is instead to make the food so easy to disintegrate that it never reaches the part of your stomach which releases these hormones to tell your body that it's full.
34:22Hannah Fry:That whole idea of Pringles being once you pop you can't stop it is literally true It is literally true. They are so pre-digested in laboratories, macerated to death, that when it enters your mouth, it just evaporates into thin air. And the evolutionary system that your body has spent millions of years perfecting is no longer capable of telling you you need to stop. That's incredible because I would never eat like three baked potatoes all at once. But if you pre-digest them for me by mashing them up into a powder and reconstituting it into a fun shape and adding a lot of fun flavors, I will blow through that and I'll still be hungry.
35:10So I will keep buying and buying and buying. And the Pringles company can make a lot more money than the potato farmer.
35:16Hannah Fry:But you're not hungry because the calories haven't been consumed. You're not hungry because your body doesn't have the same glucose input. You're hungry because you have overridden the systems that your body has in place to tell you when to stop eating. Right. right, which is wild. So what GLP-1 is doing in a world where all of these products exist, all of these super processed, ultra processed foods, it's basically like there is this little sort of arms race going on within your own body. So it's like, it's extra capitalism rather than less capitalism. It's like you had the capitalism of the food companies kind of like make people eat more, more, more, more, more.
36:04Hannah Fry:And now you've got pharmaceutical companies being like, hey, here's the war against it. So then the solution, if I'm like trying to sell a lot of food, is that in order to keep hitting my benchmarks for profits, I need to make the food probably just more expensive. I need to find a way to say, look, you're going to buy half as much, but now it's like so organic or it's got just the right trendy thing in it that It's worth paying twice as much for, whew, we're not losing money. Or you could do the other thing, which is what apparently some companies are doing, which is to start researching anti-GLP1 foods.
36:44Whoa, that's it, isn't it? The third option is to just buy the GLP company and then you're like, you know, you're going around and around and around. You sell the food and the toilet paper. You're just there for the whole cycle. So, wow. So anti-GLP food additives spark a desire that these GLP-1, I mean, that's not really what they are. They're modified versions of the GLP-1 hormone.
37:12Hannah Fry:Yeah, you can think of them as GLP-1s. Got it. So yeah, finding some additive that makes, that sparks a desire for more that GLP-1, like medicines, cannot touch would be a goldmine. The thing I think that's really interesting about the GLP-1 stuff, that is actually sort of aside from the food industry, is that the effect that it has on the brain does appear to go beyond just not wanting to eat. That's what I've heard. I've tried them, right? I've had them in the past. And you hear people describe food noise. Okay. And actually, I think Oprah Winfrey said something about this when she started on somaglutide.
37:56Hannah Fry:She was saying that it just hadn't occurred to her that people who were thin, they didn't think about it. It's not that they were so capable and strict and able to resist. It's just that they didn't have to fight the battle in the first place. That's right. They weren't resisting anything. It wasn't there in the first place. Yeah, exactly. And so I've definitely had that experience of this food noise being turned down, that dial of food noise being turned down. I absolutely had that experience. But there is this evidence that actually it turns down the dial on all kinds of other overconsumption behaviors.
38:30Hannah Fry:So alcohol, for example, smoking, even gambling, which is incredibly fascinating that actually you could potentially satiate that with a GLP-1 mimicker. Yeah. And like we've said, satiate almost isn't the word because you're actually cutting away the desire at the root. It's not there to be sated. There just isn't. You're just, you exist without the desire and the need and the drive to consume, whether it be food or or even experiences like gambling. That is part of human experience, though. So I have heard people complain about how, like, yeah, I'm not, like, desiring a bunch of sweet pies. But at the same time, my love for my grandmother's pies was a big part of our relationship, and now it's gone.
39:24Hannah Fry:Yeah. I mean, I would say, when I have been on it, it's not that food taste less delicious. It's not that you can't plan and enjoy the planning of a really amazing meal. You know, it's not like that. It's just that you, you know, I remember the first week when I had taken it and I was in a hotel in New York, so I was really jet lagged. And like normally in that situation, I will order room service and I will like have a massive burger and I'll sit on the bed and I'll watch a stupid film and I'll just eat the entire thing. Right. And I wanted to do exactly the same thing. I was in a bathroom, you know, whatever.
40:01Hannah Fry:I was there, I was ready. And I had this massive burger and I had two or three bites and it was great. And then I was done. Right. Right. It just stopped. So does it have an effect on our desire to keep scrolling on social media? Like that's another one that goes like, I can't get enough. And I just, I need to check my phone. But we're not seeing the same effect there. I haven't seen any evidence on that. There was one really big hope actually about how it might end up having an impact on the development of Alzheimer's in the brain. Really? There was this hope that actually having GLP-1 and these receptors in the brain might end up having this really positive impact on dementia and specifically Alzheimer's.
40:45Hannah Fry:But they did this really big trial with people early stage dementia, early stage Alzheimer's, I should say. And although some of the things sort of around it were improved actually really there was no difference to placebo which is kind of i think people were kind of were pretty disappointed that this might be this panacea that actually you know cures sort of sort of solves all kinds of of human ills that would have been huge imagine that if we if we had medications for dementia for cognitive decline And then what comes after that? That's always been my question. It used to be the heart. People can survive heart issues better now, but then you live long enough to hit dementia.
41:34After that, you live long enough for what? What's the next thing?
41:38Hannah Fry:Yeah, I totally agree. I totally agree. And I think that actually, I mean, this thing that I've mentioned a couple of times in this program about how scientists are taking an existing protein or existing peptide, and then they're redesigning it, and they're adding a bit here and adding a bit there. There's this explosion of research in this type of biology in a really, really, really exciting way, accelerated bluntly by the amazing use of AI, very domain specific, very focused, but a sort of AI assisted way to understand how these molecules and proteins interact with one another. What does the AI do here?
42:16Hannah Fry:There's one in particular, which is called alpha fold. All of the stuff that I'm describing, all of the things about proteins, when you get down to that level, it's all about the physical structure of these chains of amino acids. They're these long, long, long ribbons of amino acids that fold in this predefined way. But getting from what the ribbon was doing, the kind of chain of molecules to what the folded pattern was, was incredibly difficult. The first person who managed to work out the folded pattern of a protein won a Nobel Prize, right? Even very recently, an entire PhD would be like, can you work out the folding of this one protein?
42:54Hannah Fry:And then this Demis Asabis, a friend of mine, who's the founder of DeepMind, him and his colleagues, particularly John Jumper, they won a Nobel Prize for this. They created an AI with the sole focus of working out how to go from the ribbon of amino acids to a folded protein and then essentially folded all the proteins that humans know about and then released it for free to the entire world. Which proteins has artificial intelligence discovered for us? Because the Gila monster, that discovery was prior to artificial intelligence. So it's not that artificial intelligence has necessarily discovered proteins, but it has given us this mechanistic understanding and ability to predict what the proteins are going to look like, how they're going to interact with molecules that might be from drugs or parts of the body that has just completely shortened in this unbelievable way, the work process that you need to go through when it comes to designing medicines, understanding diseases.
44:00Hannah Fry:I mean, this is like, For me, I think this whole thing about Alzheimer's that we were talking about a moment ago, I don't know, if I was a betting woman, I would put money on the fact that we will come up with some miracle, what feels like a miracle to us now. I think that there is going to be some miracle intervention for Alzheimer's within the next 10 years or so, purely because of how these AI techniques have just completely accelerated our ability to understand these domains. Right. Also, my dad had Alzheimer's, right? So I'm on the list. Okay. Yeah, my grandfather did too. So and it's been a big cause for the curiosity box for the work I do there is is just brain health in general, whether it be cognitive decline or otherwise, man, just but like a lot of other innovations, it's one of those like there's two doors, and you can use it to find these medicines.
44:56You can also use it to find their antidotes, right? Okay, so we figured out a way to quell the desire, but we could also create desires that slip through. And you've got this arms race, which is the story of human technology.
45:10Hannah Fry:It absolutely is. And there's definitely some quite serious downsides to the potential of biological weapons, biological warfare, all kinds of potential things on the horizon. Well, sure. And these ups and downs were always there in the human story. But now we can get to them faster, which can be even greater or even worse. It's just accelerated. Lots more on the horizon, I think, with all of this stuff. Yeah, that's my little tour, the history and wonder of GLP-1s and the little family. And the little family we created. Yeah, I love that. But I found this fascinating because I actually had not learned any of this.
45:57It was about time that I understood this phenomenon and what's driving it.
46:02Hannah Fry:All right. Well, good stuff. As ever, if you would like to send us your questions, your ideas, anything you like, you can email us, therestiscienceatgoldhanger.com. Leave us a comment on our YouTube or on Spotify or send us a little message on Reddit. We read them all. Or just yell really loud out your window. We might hear you. But at the very least, please subscribe to us on YouTube or follow us wherever you listen to podcasts. And we will see you next time. Bye-bye.
46:49Hannah Fry:is the only purest thing in this world. Return to Pandora on Disney+. It will be an adventure for the whole family. And watch the Oscar-winning phenomenon at home. This is sick! Avatar Fire and Ash, now streaming on Disney+. Rated PG-13. Most AI coverage leaves you with one of two impressions. Everything is about to change, or everything is about to end. I'm NLW, and on my show, the AI Daily Brief, I offer something more useful. Clear daily analysis of the stories that actually matter. Is the new model really better or just better on benchmarks? Should your team build agents or buy them? What does the latest lab drama mean for the tools you use every day?
47:28Plus, hands-on deep dives that give you AI skills you can use right now. Check out the AI Daily Brief and discover why we're the top AI show on Spotify. A burst pipe. A dead water heater. The AC calling it quits. Who do you call? HomeServe is an easy way to handle unexpected home repairs. With plans covering stuff, basic homeowners insurance usually won't. Instead of scrambling for a contractor, you make one call to get the repair process started. Join the millions of customers who trust HomeServe right now. Go to homeserve.com slash podcast for 50 % less your first year. That's homeserve.com slash podcast.
48:04Savings compared to renewal price void in Florida.
From the publisher
How did the Gila monster, a desert lizard that eats just five times a year, help unlock the science behind Ozempic, Wegovy and Mounjaro?In this episode of The Rest Is Science, Professor Hannah Fry and Michael Stevens (Vsauce) trace the strange journey from a molecule found in lizard venom to medicines reshaping diabetes and weight-loss treatment, exploring how GLP-1 helps regulate blood sugar, appetite and the hum of ‘food noise’.Early evidence suggests their effects may extend far beyond food, quieting cravings for alcohol and cigarettes, and even the urge to gamble. What might this reveal about the biology of wanting itself, and how much control do any of us really have over what we crave?-------------------For more information about Cancer Research UK, their research, breakthroughs and how you can support them, visit https://www.cancerresearchuk.org/our-research/rest-is-scienceCancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ.-------------------Find The Rest Is Science all over the internet by clicking here.-------------------Video Producer: Adam Thornton + Teo Ayodeji-Ansell + Jack MeekAnimator: Sam BensonVideo & Social: Bex TyrrellAssistant Producer: Lucy LipscombeProducer: Simona RataSenior Producer: Lauren Armstrong-CarterChief Digital Officer: Samuel OakleyExec Producer: Neil Fearn
Learn more about your ad choices. Visit podcastchoices.com/adchoices
